Totaligent, Inc. TGNT
Set alert
0.00 USD 0.00 -35.71%
At close · Oct 30
0.004 Day range 0.006
0.004 52-week range 0.043
- YTD
- -77.50%
- 1 year
- -88.75%
- Open
- 0.006
- Prev close
- 0.007
- Mkt cap
- 1.71M
- Vol
- 577.03K
- Avg vol
- 82.98K
- EPS
- 0.00
- P/E
- 0.00
More statistics
- Low
- 0.004
- High
- 0.006
2Y chart
Signals (78)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 30, 2026 | 4 days ago |
| SMA: Bearish | Oct 6, 2026 | 4 weeks ago |
| SMA: Bullish | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 30, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| SMA: Bullish | Aug 27, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 13, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 14, 2026 | 3 months ago |
| SMA: Bearish | Jun 1, 2026 | 5 months ago |
| MACD: Sell Signal | May 28, 2026 | 5 months ago |
| SMA: Bearish | May 19, 2026 | 5 months ago |
| SMA: Bullish | May 18, 2026 | 5 months ago |
| SMA: Bearish | May 13, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| SMA: Bullish | May 12, 2026 | 5 months ago |
| MACD: Buy Signal | May 12, 2026 | 5 months ago |
| RSI: Overbought | May 12, 2026 | 5 months ago |
| MACD: Sell Signal | May 4, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 28, 2026 | 6 months ago |
Newest 20 of 78.
Financials — quick view
TGNT Revenue — quarterly 54.08M
TGNT Net income — quarterly -260.00M
TGNT EPS — quarterly -4.31
News
- Totaligent Opens Phase I Founders Pilot: Invite-Only Real-World Deployment Begins
- Totaligent Publishes White Paper No. 1: The Marketing Stack Is Dead.
- Totaligent Announces Featured Speaking Role at U.S.–Taiwan Innovation Forum, Advancing Global Biologics and Medical Tourism Collaboration
- Totaligent Announces Formation of Joint Venture with GloMed Solutions to Commercialize Advanced Biologics in Japan and APAC
- Totaligent Closes Strategic Acqui-Hire of Aetherium Medical Platform
- Totaligent Enters APAC Medical Tourism Market at Historic Inflection Point, as Global Healthcare Travel Surges Toward $274 Billion
- FDA's AI Push Ignites a new Biotech Arms Race and Totaligent may be quietly Positioning Itself at the Center
- Totaligent Executes Definitive Agreement for Strategic Acqui-Hire of Aetherium Medical Platform
- Totaligent Executes Binding LOI for Joint Venture and Acquisition of GloMed Solutions
- Totaligent Evaluates Relaunch of Previously Operated Crypto Mining Activities as Part of 2026 Strategy
Your note
Sign in to keep a note on TGNT — it syncs with the Stock Master app.